SCHEMBL7680558

SCHEMBL7680558

COc1nc2cc(Cl)c(Cl)c(-c3nn(C)nc3-c3ccccc3)c2nc1OC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
NR1I3 Q14994 2/20 0.37
MAT2A P31153 2/20 0.36
RORC P51449 2/20 0.34
WHR1 P49842 1/20 0.34
MAPT P10636 2/20 0.33
MEN1 O00255 1/20 0.33
MAPK1 P28482 1/20 0.33
CASP1 P29466 1/20 0.33
BRCA1 P38398 1/20 0.33
HTT P42858 1/20 0.33
CASP7 P55210 1/20 0.33
KMT2A Q03164 1/20 0.33
KEAP1 Q14145 1/20 0.33
NFE2L2 Q16236 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27476598 0.86 SMN1; SMN2 (0.39) SMN1; SMN2NPC1RAB9ANFKB1NFKB2
SCHEMBL7678666 0.83 RORC (0.33) SMN1; SMN2NPC1RAB9ANFKB1NFKB2
SCHEMBL7681595 0.81 NR1I3 (0.37) SMN1; SMN2NPC1RAB9ANFKB1NFKB2
SCHEMBL7683114 0.81 SMN1; SMN2 (0.38) SMN1; SMN2NPC1RAB9ANFKB1NFKB2
SCHEMBL7675073 0.77 NPC1 (0.36) SMN1; SMN2NPC1RAB9ANFKB1NFKB2
SCHEMBL7682758 0.73 CYP11B2 (0.46) SMN1; SMN2NPC1RAB9AMAPTMEN1
SCHEMBL7676130 0.72 MAPT (0.40) SMN1; SMN2NPC1RAB9ARORCMAPT
SCHEMBL7673858 0.72 RORC (0.31) NR1I3RORC
SCHEMBL7672900 0.72 RORC (0.31) SMN1; SMN2NPC1RAB9ANFKB1NFKB2
SCHEMBL7676249 0.72 HRH4 (0.36) PTGESHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US disclosed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP disclosed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP disclosed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO disclosed